Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Neuroblastoma 10Osteosarcoma 3Ganglioneuroblastoma 2Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Neoplasm, Residual 1Medulloblastoma 1Leiomyosarcoma 1Glioma 1Glioblastoma 1Ependymoma 1Diffuse Intrinsic Pontine Glioma 1Brain Neoplasms 1

Interventions

Radiotherapy 5Temozolomide 4Radiation 3Irinotecan 3Bevacizumab 3ribociclib 2abemaciclib 2Vorinostat 2Mebendazole 2Everolimus 2Dasatinib 2vandetanib 1temsirolimus 1sargramostim 1reolysin 1pembrolizumab 1ovex 1nimotuzumab 1irinotecan sucrosofate 1dinutuximab 1crenolanib 1adavosertib 1Vincristine 1Valproic Acid 1Sirolimus 1Re-Irradiation 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiation Dose Hypofractionation 1Piperazine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Diffuse Intrinsic Pontine Glioma × dinutuximab × Clear all
NCT04238819 2026-03-02

A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma

Eli Lilly and Company

Phase 1/2 Completed
47 enrolled 36 charts
CNSSarcoma

Diffuse Intrinsic Pontine Glioma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡